Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:4011-4018

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sosunov, E. A.
Right arrow Articles by Rosen, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sosunov, E. A.
Right arrow Articles by Rosen, M. R.

(Circulation. 1997;96:4011-4018.)
© 1997 American Heart Association, Inc.


Articles

Effects of Quinidine on Repolarization in Canine Epicardium, Midmyocardium, and Endocardium

I. In Vitro Study

Eugene A. Sosunov, PhD; Evgeny P. Anyukhovsky, PhD; ; Michael R. Rosen, MD

From the Department of Pharmacology and Pediatrics, College of Physicians and Surgeons of Columbia University, New York, NY.

Correspondence to Michael R. Rosen, MD, Gustavus A. Pfeiffer Professor of Pharmacology, Professor of Pediatrics, College of Physicians and Surgeons of Columbia University, Department of Pharmacology, 630 W 168 St, PH 7West-321, New York, NY 10032. E-mail franeye{at}cudept.cis.columbia.edu

Background The antiarrhythmic action of quinidine is associated with a slowing of conduction and prolongation of repolarization. The latter effect has no consistent correlation with quinidine actions on action potential duration (APD) in isolated tissue experiments. To enhance our understanding of the mechanisms of quinidine action, we studied its effect on APD in canine epicardial, midmyocardial, and endocardial tissues.

Methods and Results Standard microelectrode techniques were used to study the effects of quinidine 2.5 to 20 µmol/L on APD in ventricular epicardial, endocardial, and transmural (M-cell) slabs at cycle lengths (CLs) from 300 to 4000 ms. Qualitatively different time courses of actions and concentration- and rate-dependent effects were seen in M cells compared with the others. In endocardium and epicardium, quinidine induced monotonic and concentration-dependent APD prolongation at all CLs. In contrast, the effects of quinidine in M cells varied from prolongation to shortening, depending on duration of superfusion, concentration, and CL. Experiments with E4031 and TTX suggested that in M cells, quinidine-induced APD lengthening was attributable to block of delayed rectifier potassium current and APD shortening was due to inhibition of TTX-sensitive steady-state sodium current.

Conclusions In vitro, there is a significant difference of quinidine effects in M cells versus epicardial and endocardial cells that appears to reflect differences in the contributions of specific ion channels to the APD at the three sites. The differences may influence the actions of quinidine on repolarization of the heart in situ and determine both the proarrhythmic and antiarrhythmic actions of the drug.


Key Words: quinidine • repolarization




This article has been cited by other articles:


Home page
CirculationHome page
D. H. Lau, C. Clausen, E. A. Sosunov, I. N. Shlapakova, E. P. Anyukhovsky, P. Danilo Jr, T. S. Rosen, C. Kelly, H. S. Duffy, M. J. Szabolcs, et al.
Epicardial Border Zone Overexpression of Skeletal Muscle Sodium Channel SkM1 Normalizes Activation, Preserves Conduction, and Suppresses Ventricular Arrhythmia: An In Silico, In Vivo, In Vitro Study
Circulation, January 6, 2009; 119(1): 19 - 27.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. T. Morita, D. P. Zipes, H. Morita, and J. Wu
Analysis of action potentials in the canine ventricular septum: No phenotypic expression of M cells
Cardiovasc Res, April 1, 2007; 74(1): 96 - 103.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
W.S. Redfern, L. Carlsson, A.S. Davis, W.G. Lynch, I. MacKenzie, S. Palethorpe, P.K.S. Siegl, I. Strang, A.T. Sullivan, R. Wallis, et al.
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
Cardiovasc Res, April 1, 2003; 58(1): 32 - 45.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
L. Carlsson
Drug-induced torsade de pointes: the perspectives of industry
Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K114 - K120.
[Abstract] [PDF]


Home page
CirculationHome page
A. Bauer, R. Becker, K. D. Freigang, J. C. Senges, F. Voss, A. Hansen, M. Muller, H. J. Lang, U. Gerlach, A. Busch, et al.
Rate- and Site-Dependent Effects of Propafenone, Dofetilide, and the New IKs-Blocking Agent Chromanol 293b on Individual Muscle Layers of the Intact Canine Heart
Circulation, November 23, 1999; 100(21): 2184 - 2190.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Merot, F. Charpentier, J.-M. Poirier, G. Coutris, and J. Weissenburger
Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol
Cardiovasc Res, November 1, 1999; 44(2): 303 - 314.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. A. Sosunov, R. Z. Gainullin, P. Danilo Jr., E. P. Anyukhovsky, M. Kirchengast, and M. R. Rosen
Electrophysiological Effects of LU111995 on Canine Hearts: In Vivo and In Vitro Studies
J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 146 - 152.
[Abstract] [Full Text]


Home page
CirculationHome page
E. P. Anyukhovsky, E. A. Sosunov, S. J. Feinmark, and M. R. Rosen
Effects of Quinidine on Repolarization in Canine Epicardium, Midmyocardium, and Endocardium : II. In Vivo Study
Circulation, December 2, 1997; 96(11): 4019 - 4026.
[Abstract] [Full Text]